The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets
Open accessAbstract
The growing number of people with diabetes worldwide suggests that diabetic retinopathy (DR) and diabetic macular edema (DME) will continue to be sight threatening factors. The pathogenesis of diabetic retinopathy is a widespread cause of visual impairment in the world and a range of hyperglycemia-linked pathways have been implicated in the initiation and progression of this condition. Despite understanding the polyol pathway flux, activation of protein kinase C (KPC) isoforms, increased hexosamine pathway flux, and increased advanced glycation end-product (AGE) formation, pathogenic mechanisms underlying diabetes induced vision loss are not fully understood. The purpose of this paper is to review molecular mechanisms that regulate cell survival and apoptosis of retinal cells and discuss new and exciting therapeutic targets with comparison to the old and inefficient preventive strategies. This review highlights the recent advancements in understanding hyperglycemia-induced biochemical and molecular alterations, systemic metabolic factors, and aberrant activation of signaling cascades that ultimately lead to activation of a number of transcription factors causing functional and structural damage to retinal cells. It also reviews the established interventions and emerging molecular targets to avert diabetic retinopathy and its associated risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985 · cited 1×
“Globally, there are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR [4].”
BackgroundAdvanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Evolving functions of endothelial cells in inflammation
Pober, J. S., & Sessa, W. C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2171 · Cited by 2,022
Alpha-lipoic acid as a biological antioxidant
Packer, L., Witt, E. H., & Tritschler, H. J. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00017-r · Cited by 1,979
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Effects of medical therapies on retinopathy progression in type 2 diabetes
The ACCORD Study Group and ACCORD Eye Study Group (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001288 · Cited by 1,311
Pirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.3.168 · Cited by 1,290
Early Photocoagulation for Diabetic Retinopathy
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38011-7 · Cited by 1,259
Du, X.-L., Edelstein, D., Rossetti, L., Fantus, I. G., Goldberg, H., Ziyadeh, F., Wu, J., & Brownlee, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12222 · Cited by 1,152
The Prevalence of Diabetic Retinopathy Among Adults in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.552 · Cited by 1,148
Keech, A., Mitchell, P., Summanen, P., O'Day, J., Davis, T., Moffitt, M., Taskinen, M.-R., Simes, R., Tse, D., Williamson, E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61607-9 · Cited by 1,109
Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103
Mancini, G. B. J., Henry, G. C., Macaya, C., O'Neill, B. J., Pucillo, A. L., Carere, R. G., Wargovich, T. J., Mudra, H., Lu¨scher, T. F., Klibaner, M. I., et al. (1996) · Circulation · doi:10.1161/01.cir.94.3.258 · Cited by 1,057
Nonenzymatic Glycosylation and the Pathogenesis of Diabetic Complications
BROWNLEE, M., VLASSARA, H., & CERAMI, A. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-4-527 · Cited by 1,007
Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
Sheetz, M. J. (2002) · JAMA · doi:10.1001/jama.288.20.2579 · Cited by 1,002
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Geraldes, P., & King, G. L. (2010) · Circulation Research · doi:10.1161/circresaha.110.217117 · Cited by 985
Photocoagulation Treatment of Proliferative Diabetic Retinopathy
(1981) · Ophthalmology · doi:10.1016/s0161-6420(81)34978-1 · Cited by 975
Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc
Wells, L., Vosseller, K., & Hart, G. W. (2001) · Science · doi:10.1126/science.1058714 · Cited by 954
Vascular endothelial growth factors and angiogenesis in eye disease
Witmer, A. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00043-5 · Cited by 927
Management of Diabetic Retinopathy: A Systematic Review
Mohamed, Q., Gillies, M. C., & Wong, T. Y. (2007) · JAMA · doi:10.1001/jama.298.8.902 · Cited by 891
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850
Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785
The Sorbitol Pathway and the Complications of Diabetes
Steinmetz, P. R., Balko, C., & Gabbay, K. H. (1973) · New England Journal of Medicine · doi:10.1056/nejm197304192881609 · Cited by 759
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
Chaturvedi, N., Sjolie, A.-K., Stephenson, J. M., Abrahamian, H., Keipes, M., Castellarin, A., Rogulja-Pepeonik, Z., & Fuller, J. H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06209-0 · Cited by 743
Early Treatment Diabetic Retinopathy Study Design and Baseline Patient Characteristics
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38009-9 · Cited by 683
Aiello, L. P., Bursell, S.-E., Clermont, A., Duh, E., Ishii, H., Takagi, C., Mori, F., Ciulla, T. A., Ways, K., Jirousek, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1473 · Cited by 665
Patz, A., Fine, S., Finkelstein, D., Prout, T., Aiello, L., Bradley, R., Briones, J. C., Myers, F., Bresnick, G., de Venecia, G., et al. (1978) · Ophthalmology · doi:10.1016/s0161-6420(78)35693-1 · Cited by 652
Schmidt, A. M., Hori, O., Brett, J., Yan, S. D., Wautier, J. L., & Stern, D. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1521 · Cited by 635
The worldwide epidemic of diabetic retinopathy
Congdon, N., Zheng, Y., & He, M. (2012) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.100542 · Cited by 632
Uribarri, J., Cai, W., Peppa, M., Goodman, S., Ferrucci, L., Striker, G., & Vlassara, H. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.4.427 · Cited by 570
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566
Isolation and Properties of Lens Aldose Reductase
Hayman, S., & Kinoshita, J. H. (1965) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45256-2 · Cited by 556
Koya, D., Jirousek, M. R., Lin, Y. W., Ishii, H., Kuboki, K., & King, G. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119503 · Cited by 536
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Nguyen, Q. D., Shah, S. M., Khwaja, A. A., Channa, R., Hatef, E., Do, D. V., Boyer, D., Heier, J. S., Abraham, P., Thach, A. B., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.08.016 · Cited by 532
PKC and the control of localized signal dynamics
Rosse, C., Linch, M., Kermorgant, S., Cameron, A. J. M., Boeckeler, K., & Parker, P. J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2847 · Cited by 477
Xia, P., Inoguchi, T., Kern, T. S., Engerman, R. L., Oates, P. J., & King, G. L. (1994) · Diabetes · doi:10.2337/diab.43.9.1122 · Cited by 477
The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient
Lorenzi, M. (2007) · Journal of Diabetes Research · doi:10.1155/2007/61038 · Cited by 472
Soulis-Liparota, T., Cooper, M., Papazoglou, D., Clarke, B., & Jerums, G. (1991) · Diabetes · doi:10.2337/diab.40.10.1328 · Cited by 447
(1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30973-6 · Cited by 446
Kolm-Litty, V, Sauer, U., Nerlich, A., Lehmann, R., & Schleicher, E. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119875 · Cited by 430
Geraldes, P., Hiraoka-Yamamoto, J., Matsumoto, M., Clermont, A., Leitges, M., Marette, A., Aiello, L. P., Kern, T. S., & King, G. L. (2009) · Nature Medicine · doi:10.1038/nm.2052 · Cited by 425
Blood Pressure, Lipids, and Obesity Are Associated With Retinopathy
van Leiden, H. A., Dekker, J. M., Moll, A. C., Nijpels, G., Heine, R. J., Bouter, L. M., Stehouwer, C. D. A., & Polak, B. C. P. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1320 · Cited by 414
O-Glycosylation of Nuclear and Cytosolic Proteins
Comer, F. I., & Hart, G. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000010200 · Cited by 361
Shohami, E., Gallily, R., Mechoulam, R., Bass, R., & Ben-Hur, T. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00181-6 · Cited by 337
Bursell, S. E., Clermont, A. C., Aiello, L. P., Aiello, L. M., Schlossman, D. K., Feener, E. P., Laffel, L., & King, G. L. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1245 · Cited by 333
Polyol pathway and diabetic peripheral neuropathy
Oates, P. J. (2002) · International Review of Neurobiology · doi:10.1016/s0074-7742(02)50082-9 · Cited by 322
Advanced glycation: an important pathological event in diabetic and age related ocular disease
STITT, A. W. (2001) · British Journal of Ophthalmology · doi:10.1136/bjo.85.6.746 · Cited by 306
The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes
Tuttle, K. R., Bakris, G. L., Toto, R. D., McGill, J. B., Hu, K., & Anderson, P. W. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2686 · Cited by 300
Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
Yang, C. W., Vlassara, H., Peten, E. P., He, C. J., Striker, G. E., & Striker, L. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9436 · Cited by 294
Sima, A. A. F., Bril, V., Nathaniel, V., McEwen, T. A., Brown, M. B., Lattimer, S. A., & Greene, D. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190905 · Cited by 293
Asnaghi, V., Gerhardinger, C., Hoehn, T., Adeboje, A., & Lorenzi, M. (2003) · Diabetes · doi:10.2337/diabetes.52.2.506 · Cited by 279
Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy
Greene, D. A., Arezzo, J. C., Brown, M. B., & the Zenarestat Study Group (1999) · Neurology · doi:10.1212/wnl.53.3.580 · Cited by 278
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
Schleicher, E. D., & Weigert, C. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07703.x · Cited by 271
Wagner, J., Jan Danser, A. H., Derkx, F. H., de Jong, T. V., Paul, M., Mullins, J. J., Schalekamp, M. A., & Ganten, D. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.2.159 · Cited by 268
Antioxidants, diabetes and endothelial dysfunction
Laight, D. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00054-7 · Cited by 267
Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin
Okamoto, T., Yamagishi, S., Inagaki, Y., Amano, S., Koga, K., Abe, R., Takeuchi, M., Ohno, S., Yoshimura, A., & Makita, Z. (2002) · The FASEB Journal · doi:10.1096/fj.02-0030fje · Cited by 258
AGEs, RAGE, and Diabetic Retinopathy
Zong, H., Ward, M., & Stitt, A. W. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0198-7 · Cited by 252
Harhaj, N. S., Felinski, E. A., Wolpert, E. B., Sundstrom, J. M., Gardner, T. W., & Antonetti, D. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0322 · Cited by 238
Kowluru, R. A., Kowluru, V., Xiong, Y., & Ho, Y.-S. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.012 · Cited by 233
Fong, D. S., Aiello, L., Gardner, T. W., King, G. L., Blankenship, G., Cavallerano, J. D., Ferris, F. L., Klein, R., & American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.1.226 · Cited by 233
Studies of Rat and Human Retinas Predict a Role for the Polyol Pathway in Human Diabetic Retinopathy
Dagher, Z., Park, Y. S., Asnaghi, V., Hoehn, T., Gerhardinger, C., & Lorenzi, M. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2404 · Cited by 231
A Randomized Trial of Sorbinil, an Aldose Reductase Inhibitor, in Diabetic Retinopathy
(1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070110050024 · Cited by 228
Kowluru, R. A., & Odenbach, S. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3233 · Cited by 227
Protein Kinase C-ζ Mediates Angiotensin II Activation of ERK1/2 in Vascular Smooth Muscle Cells
Liao, D.-F., Monia, B., Dean, N., & Berk, B. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6146 · Cited by 219
Chen, Y.-Q., Su, M., Walia, R. R., Hao, Q., Covington, J. W., & Vaughan, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8225 · Cited by 217
Oxidative Stress and Antioxidant Treatment in Diabetes
SCOTT, J. A., & KING, G. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1331.020 · Cited by 206
Kitada, M., Koya, D., Sugimoto, T., Isono, M., Araki, S.-I., Kashiwagi, A., & Haneda, M. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2603 · Cited by 204
El-Remessy, A. B., Behzadian, M. A., Abou-Mohamed, G., Franklin, T., Caldwell, R. W., & Caldwell, R. B. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64332-5 · Cited by 203
Obrosova, I. G., Minchenko, A. G., Vasupuram, R., White, L., Abatan, O. I., Kumagai, A. K., Frank, R. N., & Stevens, M. J. (2003) · Diabetes · doi:10.2337/diabetes.52.3.864 · Cited by 201
Aldose reductase inhibitors: therapeutic implications for diabetic complications
Oates, P. J., & Mylari, B. L. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.2095 · Cited by 197
Retinal glutamate in diabetes and effect of antioxidants
Kowluru, R. A., Engerman, R. L., Case, G. L., & Kern, T. S. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00112-1 · Cited by 195
Yamagishi, S., Fujimori, H., Yonekura, H., Yamamoto, Y., & Yamamoto, H. (1998) · Diabetologia · doi:10.1007/s001250051089 · Cited by 194
A Redox-triggered Ras-Effector Interaction
Deora, A. A., Win, T., Vanhaesebroeck, B., & Lander, H. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29923 · Cited by 180
Obrosova, I. G., Pacher, P., Szabó, C., Zsengeller, Z., Hirooka, H., Stevens, M. J., & Yorek, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.234 · Cited by 178
Nakamura, M., Barber, A. J., Antonetti, D. A., LaNoue, K. F., Robinson, K. A., Buse, M. G., & Gardner, T. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108594200 · Cited by 175
Kelly, D. J., Zhang, Y., Hepper, C., Gow, R. M., Jaworski, K., Kemp, B. E., Wilkinson-Berka, J. L., & Gilbert, R. E. (2003) · Diabetes · doi:10.2337/diabetes.52.2.512 · Cited by 166
Serum markers of oxidative stress and severity of diabetic retinopathy.
Hartnett, M. E., Stratton, R. D., Browne, R. W., Rosner, B. A., Lanham, R. J., & Armstrong, D. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.234 · Cited by 164
FONG, D. S., GIRACH, A., & BONEY, A. (2007) · Retina · doi:10.1097/iae.0b013e318042d32c · Cited by 163
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Sugiyama, S., Miyata, T., Ueda, Y., Tanaka, H., Maeda, K., Kawashima, S., Van Ypersele de Strihou, C., & Kurokawa, K. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v991681 · Cited by 162
Liou, G. I., Auchampach, J. A., Hillard, C. J., Zhu, G., Yousufzai, B., Mian, S., Khan, S. H., & Khalifa, Y. M. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2196 · Cited by 154
Kador, P. F. (1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070110117035 · Cited by 154
Satofuka, S., Ichihara, A., Nagai, N., Noda, K., Ozawa, Y., Fukamizu, A., Tsubota, K., Itoh, H., Oike, Y., & Ishida, S. (2009) · Diabetes · doi:10.2337/db08-0254 · Cited by 149
Klein, R., Zinman, B., GARDINER, R. J., Suissa, S., Donnelly, S. M., Sinaiko, A. R., Kramer, M. S., Goodyer, P., Moss, S. E., Strand, T. D., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.2.527 · Cited by 142
Yki‐Järvinen, H., Daniels, M. C., Virkamäki, A., Mäkimattila, S., DeFronzo, R. A., & McClain, D. A. (1996) · Diabetes · doi:10.2337/diab.45.3.302 · Cited by 140
a (1985) · Ophthalmology · doi:10.1016/s0161-6420(85)34002-2 · Cited by 140
Paradoxical Effects of Green Tea (Camellia Sinensis) and Antioxidant Vitamins in Diabetic Rats
Mustata, G. T., Rosca, M. G., Biemel, K. M., Reihl, O., Smith, M. A., VISWANATHAN, A., Strauch, C., Du, Y., Tang, J., Kern, T. S., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.2.517 · Cited by 138
Thiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products
Marx, N., Walcher, D., Ivanova, N., Rautzenberg, K., Jung, A., Friedl, R., Hombach, V., Caterina, R. D., Basta, G., Wautier, M., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2662 · Cited by 136
Identification of a Novel Inhibitor of the Canonical Wnt Pathway
Park, K., Lee, K., Zhang, B., Zhou, T., He, X., Gao, G., Murray, A. R., & Ma, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01211-10 · Cited by 131
N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients
Wautier, M.-P., Massin, P., Guillausseau, P.-J., Huijberts, M. S., Levy, B. I., Boulanger, É., Laloi-Michelin, M., & Wautier, J. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70006-x · Cited by 130
Nerlich, M. L., Sauer, U., Kolm-Litty, V., Wagner, E., Koch, M., & Schleicher, E. D. (1998) · Diabetes · doi:10.2337/diab.47.2.170 · Cited by 123
Preventive effects of rutin on the development of experimental diabetic nephropathy in rats
Hao, H., Shao, Z.-M., Tang, D., Lü, Q., Xu, C., Yin, X., Wu, J., & Chen, H. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.09.003 · Cited by 116
Beneficial effects of the nutritional supplements on the development of diabetic retinopathy
Kowluru, R. A., Zhong, Q. P. W., dos Santos, J. M., Ajjeya, M. T., Putt, D., & Gierhart, D. L. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-8 · Cited by 114
Picard, S., Parthasarathy, S., Fruebis, J., & Witztum, J. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6876 · Cited by 107
Balasubbu, S., Sundaresan, P., Rajendran, A., Ramasamy, K., Govindarajan, G., Namperumalsamy, P., & Hejtmancik, J. F. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-158 · Cited by 105
Nakamura, K., Yamagishi, S., Nakamura, Y., Takenaka, K., Matsui, T., Jinnouchi, Y., & Imaizumi, T. (2005) · Microvascular Research · doi:10.1016/j.mvr.2005.10.002 · Cited by 102
Aldose Reductase / Polyol Inhibitors for Diabetic Retinopathy
Obrosova, I. G., & Kador, P. F. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794480642 · Cited by 102
Srivastava, A. K. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.9.1.85 · Cited by 101
Drel, V. R., Pacher, P., Ali, T. K., Shin, J., Julius, U., El‐Remessy, A. B., & Obrosova, I. G. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.6.667 · Cited by 99
Recombinant Advanced Glycation End Product Receptor Pharmacokinetics in Normal and Diabetic Rats
Renard, C., Chappey, O., Wautier, M.-P., Nagashima, M., Lundh, E., Morser, J., Zhao, L., Schmidt, A. M., Scherrmann, J., & Wautier, J. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.54 · Cited by 91
Davis, M. D., Sheetz, M. J., Aiello, L. P., Milton, R. C., Danis, R. P., Zhi, X., Girach, A., Jiménez, M. C. H., & Vignati, L. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2473 · Cited by 88
Chan, P.-S., Kanwar, M., & Kowluru, R. A. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.10.002 · Cited by 87
Huang, J., Guh, J., Hung, W., Yang, M., Lai, Y., Chen, H., & Chuang, L. (1999) · Biochemical Journal · doi:10.1042/bj3420231 · Cited by 80
Oxidative Retinal Products and Ocular Damages in Diabetic Patients
Grattagliano, I., Vendemiale, G., Boscia, F., Ferrari, T. M., Cardia, L., & Altomare, E. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00059-8 · Cited by 79
Yamagishi, S., Matsui, T., Nakamura, K., Takeuchi, M., & Imaizumi, T. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.04.002 · Cited by 75
Drel, V. R., Xu, W., Zhang, J., Kador, P. F., Ali, T. K., Shin, J., Julius, U., Slusher, B. S., El‐Remessy, A. B., & Obrosova, I. G. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2191 · Cited by 75
Braida, D., Pegorini, S., Arcidiacono, M. V., Consalez, G. G., Croci, L., & Sala, M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00569-x · Cited by 73
Mokini, Z., Marcovecchio, M. L., & Chiarelli, F. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.11.018 · Cited by 72
Li, Y., Roux, C., Lazereg, S., Caër, J. L., Laprévôte, O., Badet, B., & Badet‐Denisot, M. (2007) · Biochemistry · doi:10.1021/bi700694c · Cited by 67
Agardh, E., Hultberg, B. L., & Agardh, C. D. (2000) · Current Eye Research · doi:10.1076/0271-3683(200007)2111-zft543 · Cited by 67
Sharma, S., Brown, G. C., Brown, M. M., Hollands, H., & Shah, G. K. (2000) · Current Opinion in Ophthalmology · doi:10.1097/00055735-200006000-00004 · Cited by 56
Wright, A. D., & Dodson, P. M. (2009) · Eye · doi:10.1038/eye.2009.189 · Cited by 55
Hull, R. L., Zraika, S., Udayasankar, J., Kisilevsky, R., Szarek, W. A., Wight, T. N., & Kahn, S. E. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00208.2007 · Cited by 53
Plasma MDA and antioxidant vitamins in diabetic retinopathy
Kumari, S., Panda, S., Mangaraj, M., Mandal, M. K., & Mahapatra, P. C. (2008) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-008-0035-1 · Cited by 51
Fenofibrate for diabetic retinopathy
Simó, R., & Hernández, C. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61608-0 · Cited by 50
Rajapakse, A. G., Ming, X., Carvas, J. M., & Yang, Z. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00756.2008 · Cited by 50
Cilenšek, I., Mankoč, S., Petrovič, M. G., & Petrovič, D. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1537-8 · Cited by 42
Mené, P., Pascale, C., Teti, A. M., BERNARDINI, S., Cinotti, G. A., & Pugliese, F. R. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1071478 · Cited by 42
Sheikpranbabu, S., Haribalaganesh, R., & Gurunathan, S. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.03.006 · Cited by 37
Robison, W. G., JACOT, J. L., Katz, M. L., & Glover, J. P. (2000) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2000.16.109 · Cited by 29
Du, J., Wang, L., Liu, X., Zhou, H., Fan, Q., Luo, J., Li, Y., Wang, J., Feng, J., & Ma, J. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.768 · Cited by 28
Hattori, T., Matsubara, A., Taniguchi, K., & Ogura, Y. (2010) · Current Eye Research · doi:10.3109/02713680903447918 · Cited by 27
Diabetic retinopathyCommentary: Treatment of diabetic retinopathy
Harding, S. P., & KOHNER, E. M. (2003) · BMJ · doi:10.1136/bmj.326.7397.1023 · Cited by 22
The Role of the Polyol Pathway in Methaemoglobin Reduction in Human Red Cells
Travis, S. F., Morrison, A. D., Clements, R. S., Winegrad, J. A. I., & Oski, F. A. (1974) · British Journal of Haematology · doi:10.1111/j.1365-2141.1974.tb06625.x · Cited by 15
Should we start all patients with diabetic retinopathy on fenofibrates?
Koshy, J., Koshy, J., Thomas, S., Kaur, G., & Mathew, T. (2013) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.120012 · Cited by 2
Cited by
Kang, Q., & Yang, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101799 · Cited by 1,066
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 635
NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes
Suryavanshi, S. V., & Kulkarni, Y. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00798 · Cited by 348
Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases
Fallah, A., Sadeghinia, A., Kahroba, H., Samadi, A., Heidari, H. R., Bradaran, B., Zeinali, S., & Molavi, O. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.022 · Cited by 259
Díaz-López, A., Babio, N., Martínez-González, M. A., Corella, D., Amor, A. J., Fitó, M., Estruch, R., Arós, F., Gómez-Gracia, E., Fiol, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1117 · Cited by 147
Metadata
- Authors
- Safi, S. Z., Qvist, R., Kumar, S., Batumalaie, K., & Ismail, I. S. B.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-18
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2008128312
- Cited by
- 257
- References
- 133
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.